Digital Library
Close Browse articles from a journal
     Journal description
       All volumes of the corresponding journal
         All issues of the corresponding volume
                                       All articles of the corresponding issues
 
                             13 results found
no title author magazine year volume issue page(s) type
1 Clinical Management of Non-Small Cell Lung Cancer with Concomitant EGFR Mutations and ALK Rearrangements: Efficacy of EGFR Tyrosine Kinase Inhibitors and Crizotinib Zhao, Yiming
2019
14 2 p. 169-178
article
2 Comparative Efficacy of CDK4/6 Inhibitors Plus Aromatase Inhibitors Versus Fulvestrant for the First-Line Treatment of Hormone Receptor-Positive Advanced Breast Cancer: A Network Meta-Analysis Guo, Qianqian
2019
14 2 p. 139-148
article
3 Distribution of ALK Fusion Variants and Correlation with Clinical Outcomes in Chinese Patients with Non-Small Cell Lung Cancer Treated with Crizotinib Su, Yudong
2019
14 2 p. 159-168
article
4 EGFR Mutations in Cell-free Plasma DNA from Patients with Advanced Lung Adenocarcinoma: Improved Detection by Droplet Digital PCR Buder, Anna
2019
14 2 p. 197-203
article
5 Inhibiting Bruton’s Tyrosine Kinase in CLL and Other B-Cell Malignancies Lucas, Fabienne
2019
14 2 p. 125-138
article
6 Pralatrexate in Chinese Patients with Relapsed or Refractory Peripheral T-cell Lymphoma: A Single-arm, Multicenter Study Hong, Xiaonan
2019
14 2 p. 149-158
article
7 Prognostic Markers for Refined Stratification of IMDC Intermediate-Risk Metastatic Clear Cell Renal Cell Carcinoma Treated with First-Line Tyrosine Kinase Inhibitor Therapy Takagi, Toshio
2019
14 2 p. 179-186
article
8 Rucaparib: A Review in Ovarian Cancer Shirley, Matt
2019
14 2 p. 237-246
article
9 Serum Alpha1-Globulin as a Novel Prognostic Factor in Metastatic Renal Cell Carcinoma Treated with Tyrosine Kinase Inhibitors Chen, Xiang
2019
14 2 p. 187-195
article
10 Synergistic Growth Inhibition by Afatinib and Trametinib in Preclinical Oral Squamous Cell Carcinoma Models Yee, Pei San
2019
14 2 p. 223-235
article
11 The Changing Landscape of Systemic Treatment of Advanced Hepatocellular Carcinoma: New Targeted Agents and Immunotherapies Marquardt, Jens U.
2019
14 2 p. 115-123
article
12 Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System Raschi, Emanuel
2019
14 2 p. 205-221
article
13 Toxicities with Immune Checkpoint Inhibitors: Emerging Priorities From Disproportionality Analysis of the FDA Adverse Event Reporting System Raschi, Emanuel

14 2 p. 205-221
article
                             13 results found
 
 Koninklijke Bibliotheek - National Library of the Netherlands